WIREDGOV

New industrial biotechnology innovation centre launches.

A new innovation centre for industrial biotechnology (IB) is forecast to increase IB related turnover to up to £3 billion by 2030, create 1500 jobs within five years and put Scotland at the forefront of a global transformation.

Funded by the Scottish Funding Council and supported by Scottish Enterprise and Highlands & Islands Enterprise, the new Industrial Biotechnology Innovation Centre (IBioIC) – hosted at the University of Strathclyde – is a key element of the National Plan for Industrial Biotechnology – Towards a Greener, Cleaner 2025.

It brings together academic and private sector partners to play a leading role in the potential £360 billion global industrial biotechnology market.

Industrial biotechnology is the use of biological substances, systems and processes to produce intermediate and final products such as pharmaceuticals, chemicals, materials and energy – both cost-effectively and with minimal adverse environmental impact.

Finance Secretary, John Swinney, joined the chairman of IBioIC, Ian Shott CBE, together with partners and stakeholders at an event today in the Edinburgh Centre for Carbon Innovation to formally launch the new Industrial Biotechnology Innovation Centre, IBioIC.

Mr Swinney said: “The creation of 1,500 new jobs is a fantastic boost for Scotland’s expanding biotechnology industry. Scotland’s chemical industry is the country’s second top exporter – equating to £3.7 billion per year – while Scotland’s life sciences sector is one of the largest and fastest-growing in Europe.

“The launch of IBioIC is predicted to add £130 million to the Scottish economy and will allow Scotland to be at the forefront of global transformational change from a largely fossil fuel-based to an industrial biotechnology-inclusive economy.

“Later today I will be urging Parliament to back my budget for 2014-15, which supports economic recovery while creating jobs and new opportunities, including through the transition to a low carbon economy. In line with today’s announcement, the most recent employment statistics show that Scotland continues to be the best performing of the four nations in the UK in terms of unemployment and employment.”

Ian Shott CBE, Chairman of IBioIC, said: “IBioIC is a collaboration of businesses and Higher Education Institutions with the ambition to be truly distinctive, world-leading and responsive to the market and technology needs of industry. Furthermore, the networks that IBioIC members bring to the partnership will be consolidated and extended to enhance connectivity and collaboration with industrial biotechnology centres worldwide.

“We aim to surpass the targets set by Scotland’s National Plan for Industrial Biotechnology by raising the estimated turnover of industrial biotechnology-related products from around £190 million currently, to between £2 billion and £3 billion by 2030.”

The Scottish Funding Council has contributed an initial £10 million towards the innovation centre, which is set to leverage over £45 million of investments within its first five years from various sources including industrial membership contributions and through external funding agencies such as RCUK, Horizon 2020 and TSB.

Laurence Howells, Interim Chief Executive of the Scottish Funding Council said: “Industrial Biotechnology has wide-reaching benefits for us all, whether it is turning waste into energy and products or improving the way we manufacture food, drink, vaccines and antibiotics. I am in no doubt of the huge contribution IBioIC will make to economic growth and job creation in Scotland, whilst reducing our impact on the environment. I’m pleased our £10 million will be used to support the essential backbone for IBioIC’s ambitious mission; its facilities, equipment, and staff”.

An independent economic assessment forecasts that IBioIC will generate around £130 million of GVA and 1,500 jobs within five years, both directly through the innovation centre and indirectly through companies involved in growing the industrial biotechnology market.

Scottish Enterprise and Highlands and Islands Enterprise (HIE), the Scottish Funding Council’s partners in the Innovation Centre programme, work intensively with companies both at home and overseas through their international arm, Scottish Development International (SDI), to encourage more companies to invest in Industrial Biotechnology. Scottish Enterprise is also leading the delivery of the National Plan for Industrial Biotechnology in partnership with HIE.

Head of chemical sciences at Scottish Enterprise, Caroline Strain, said: “There are currently around 43 businesses actively involved in IB projects in Scotland, including world leading companies such as GSK, Ingenza and INEOS.

“Working collaboratively with our private and public sector partners, we aim to support these companies to build on their existing expertise as well as encourage more businesses to consider the impact and benefits sustainable high-value manufacturing and industrial biotechnology activities can contribute to their growth journey.

“IBioIC will play a key role in this process, supporting greater innovation and collaboration between industry and academia, and help to support our ambition of Scotland becoming an international hub for IB excellence.”

Chief executive of HIE, Alex Paterson, added: "Industrial Biotechnology is important to a number of sectors across the Highlands and Islands such as renewable energy, natural products and forestry. I welcome the creation of this new Innovation Centre and the contribution it can make to the region's future growth.”

IBioIC will involve all 13 Scottish Higher Education Institutions that are active in biotechnology research and will be co-ordinated by the University of Strathclyde.

Speaking on behalf of IBioIC’s academic partners, Principal of the University of Strathclyde Professor Sir Jim McDonald said: “As a single, national facility, IBioIC will enable Scotland – with its established industry base, world-class academic expertise and natural resources – to accelerate our globally-distinctive positioning and capability in the industrial biotechnology market.

“IBioIC, hosted here at Strathclyde, will ensure that Scotland capitalises on its resources and the synergies of its industrial and academic communities to gain economic advantage in this endeavour. The coherence and partnership within Scotland’s universities have been a key foundation for the creation of this exciting new venture. The industrial leadership that has been attracted to this research and innovation investment is enormously encouraging and demonstrates the value of collaboration and shared vision between government, industry and academia.”